Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$22.97 - $30.58 $1,148 - $1,529
50 New
50 $1,000
Q4 2022

Feb 13, 2023

BUY
$22.28 - $38.71 $1,114 - $1,935
50 New
50 $1,000
Q1 2021

May 24, 2021

SELL
$126.27 - $191.71 $0 - $0
0 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$81.94 - $135.34 $3,195 - $5,278
-39 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$73.3 - $89.48 $2,858 - $3,489
39 New
39 $3,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.